The potent anti-cancer agent doxorubicin (DOX) induces apoptosis of rapidly proliferating cells by inhibiting cellular proteasomes. The aim of the present study was to determine whether DOX modulates the level of expression and function of proteasomes in feline injection-site sarcoma (FISS). Tissue extracts from primary sarcoma lesions and the related healthy subcutis of 18 cats affected by FISS were investigated. Nine of these cats had received neoadjuvantDOXtreatment and nine cats did not receive this therapy. There was enhanced proteasome expression in FISS, but this was not affected by administration of DOX. This finding may account for the low clinical effectiveness of DOX therapy in FISS and provides the rationale for developing new therapeutic protocols aimed at achieving better proteasomal inhibition in FISS and other tumours that respond poorly to DOX therapy
Proteasomes are not a target for doxorubicin in feline injection-site sarcoma
CERRUTI, Fulvia;MARTANO, Marina;MORELLO, Emanuela Maria;BURACCO, Paolo;CASCIO, Paolo
2010-01-01
Abstract
The potent anti-cancer agent doxorubicin (DOX) induces apoptosis of rapidly proliferating cells by inhibiting cellular proteasomes. The aim of the present study was to determine whether DOX modulates the level of expression and function of proteasomes in feline injection-site sarcoma (FISS). Tissue extracts from primary sarcoma lesions and the related healthy subcutis of 18 cats affected by FISS were investigated. Nine of these cats had received neoadjuvantDOXtreatment and nine cats did not receive this therapy. There was enhanced proteasome expression in FISS, but this was not affected by administration of DOX. This finding may account for the low clinical effectiveness of DOX therapy in FISS and provides the rationale for developing new therapeutic protocols aimed at achieving better proteasomal inhibition in FISS and other tumours that respond poorly to DOX therapyFile | Dimensione | Formato | |
---|---|---|---|
j comp path 2010.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
365.11 kB
Formato
Adobe PDF
|
365.11 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
529486 j comp pathol 10.pdf
Open Access dal 01/01/2012
Tipo di file:
POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione
443.03 kB
Formato
Adobe PDF
|
443.03 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.